Megan DeFauw
Managing Director & Partner
Dallas
Megan DeFauw is a core member of Boston Consulting Group’s Health Care and Operations practices. She focuses on biopharma and medtech manufacturing and supply chain. Since joining BCG in 2011, Megan has worked extensively in strategy and operations topics including network design, quality, organization design, large-scale transformation, post-merger integration, and divestitures. Megan leads the firm’s work in quality for North America, as well as for cost transformation in health care operations.
Megan has worked with pharmaceutical and medtech clients across all phases of acquisitions and divestitures, as well as manufacturing network strategy and redesign, operations transformation, and quality remediation and transformation.
As the current crisis demonstrates, biopharma and medtech companies need to safeguard their networks against unanticipated disruptions. Here’s how.
企業はパンデミックにより露呈した構造的問題に対処するため、グローバル生産・供給ネットワークを再考し、レジリエンスを高める必要があります――たとえ、それがコスト増につながるとしても。
